Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health


Personal tools

You are here: Home / Biomarkers / KIF1A



This biomarker is also known as:
  • HSN2C,
  • Kinesin Family Member 1A,
  • Spastic Paraplegia 30 (Autosomal Recessive),
  • SPG30,
  • Unc-104- And KIF1A-Related Protein,
  • Kinesin-Like Protein KIF1A,
  • Microtubule-Based Motor KIF1A,
  • ATSV,
  • Axonal Transport Of Synaptic Vesicles,
  • Kinesin, Heavy Chain, Member 1A, Homolog Of Mouse,
  • C2orf20,
  • HUnc-104,
  • Axonal Transporter Of Synaptic Vesicles,
  • Tmp_locus_27,
  • Chromosome 2 Open Reading Frame 20,
  • UNC104,
  • MRD9,

View in BioMuta


From NCBI Entrez Gene: The protein encoded by this gene is a member of the kinesin family and functions as an anterograde motor protein that transports membranous organelles along axonal microtubules. Mutations at this locus have been associated with spastic paraplegia-30 and hereditary sensory neuropathy IIC. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Apr 2012]


QA State: Curated
Type: Gene
Short Name:


There are no datasets associated with this biomarker.


The following organs have data associated with this biomarker…

Head & neck, NOS


Phase: One
QA State: Curated


No additional data available.

Performance Comment

KIF1A is one of eight genes on a panel of differentially methylated genes from normal and OSCC clinical samples from patients with heterogenous risk profiles chosen for further validation.  The eight genes are: HOXA9, NID2, GATA4, KIF1A, EDNRB, MCAM, DCC, and CALCA.


This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at if you should have access to this biomarker.

2016 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take place March 14–15, 2016 in Bethesda, Maryland.

Announcement 11/05/2015

Thank you to everyone who made the 29th EDRN Steering Committee Meeting a success. The orientation for new and continuing EDRN PIs will be held Monday-Tuesday, March 14-15, 2016, on the NCI campus. More information will be available later this autumn.

Announcement 06/30/2015

A funding opportunity for a new pancreatic cancer initiative, called The Pancreatic Cancer Detection Consortium (U01), has been released. For more information, please go to /grants/guide/ pa-files/ PAR-15-289.html.